Breakthrough Hemostatic Medical Device for severe bleeding management with huge untapped potential
A groundbreaking invention in protein cross-binding has led to the development of a unique, patented platform technology with applications across multiple human health areas.
Our first candidate in the pipeline is a unique Hemostatic Medical Device for severe bleeding management – the first and only effective & safe product in the world for severe arterial bleeding using tissue factor – a product with a huge untapped potential.
Tissue-Link develops novel Medical Device solutions for unmet needs inside and outside the surgical field.
Founded on June 24, 2019, Tissue-Link ApS is an innovative biotechnology company based in the Greater Copenhagen area, Denmark. The company was created to address critical challenges in controlling severe bleeding through advanced hemostatic products. Tissue-Link has made significant progress in developing proprietary technology that leverages tissue factor, a natural human protein, to enhance hemostasis, particularly in acute and surgical settings.